Clinical Trials List
Protocol NumberITpem
Active
2023-05-01 - 2027-12-31
Phase II
Recruiting1
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 李政家 Division of Orthopedics
- Chi-Lu Chiang Division of Hematology & Oncology
- Yuh-Min Chen Division of Thoracic Medicine
- Hsu-ching Huang Division of Hematology & Oncology
- 趙恒勝 Division of Thoracic Medicine
- 廖映庭 Division of Hematology & Oncology
- YEN-HAN TSENG Division of Hematology & Oncology
- 蕭慈慧 Division of Thoracic Medicine
- Chia-I Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
23 participants
-
Global
23 participants
